LRPPRC gene replacement therapy preserves cardiac function and prevents premature death in a mouse model of mitochondrial disease

Authors: S. Zanin, F. Lager, M. Simon-Sola, C. Gaborit, G. Renault, F. Mingozzi, A. Rotig, M. Cavazzana, M. Metodiev, B. Ruzzenente

bioRxiv preprint
DOI: 10.64898/2026.11.12.762002 - DOI (bioRxiv: Genetics)
Published on 13 Nov. 2026
License: CC BY 4.0
Abstract

Pathogenic variants in LRPPRC disrupt mitochondrial gene expression, causing severe and incurable mitochondrial disease with neurological involvement accompanied by hepatopathy or cardiomyopathy. The development for gene therapy for LRPPRC-linked disease is hindered by the large LRPPRC coding sequence exceeding AAV cargo capacity when combined with classical regulatory elements. Here, we engineered compact single rAAV9 vectors expressing human or mouse LRPPRC and administered them intravenously to heart and skeletal muscle-specific Lrpprc knockout mice. This approach restored cardiac LRPPRC expression, preserved oxidative phosphorylation (OXPHOS) function, prevented cardiomyopathy and markedly extended survival. While skeletal muscle rescue was partial, the therapy effectively prevented fatal cardiac dysfunction. These findings provide the first in vivo proof-of-concept that AAV-mediated LRPPRC gene replacement can preserve OXPHOS function and prevent lethal cardiomyopathy, supporting its potential as a therapeutic strategy for mitochondrial disease linked to LRPPRC deficiency.

The papers around it, by date and closeness

Higher is closer to this paper; left is older. Lines join papers close to each other: groups of lines are sub-topics. Select a point to see why it is there. Back to the summary of this paper

How to read this map? Illustrated guide

Closest papers Prior work it builds on Papers that cite it

Papers around this one

Ranked by how close their title and abstract are to this paper’s. Select some to read them together.

Closest papers

  1. Close Broader context
    PKR drives neuropathology in a mouse model of Leigh syndrome
    M. Gonzalez-Torres, P. Bianchi, M. Blanco-Ramos et al. · 2026 · bioRxiv preprint · AI summary available

    PKR drives mitochondrial neuropathology in Ndufs4-deficient Leigh syndrome mice, whereas this paper uses Lrpprc deficiency to study cardiac disease and gene replacement.

    In short

    PKR contributes to neurological decline and inflammation in Ndufs4-deficient mice, and its removal delays disease without restoring mitochondrial respiration.

  2. Close Broader context
    Prevention of prion disease symptoms in mice with deep PrP lowering
    J. E. Gentile, J. E. Farley, M. N. Kelemen et al. · 2026 · bioRxiv preprint · AI summary available

    This study lowers PrP with siRNA to prevent prion symptoms in mice, rather than replacing a mitochondrial disease gene with AAV.

    In short

    Deep PrP lowering with a C16-conjugated siRNA prevented symptoms through 500 days in prion-infected mice treated early and extended survival when treatment began after symptoms.

  3. Related
    Nationwide Functional Profiling Enables Clinical Reclassification of KCNH2 Variants in the French LQT2 Population
    B. Ribeiro de Oliveira, M. Alameh, S. Feliciangeli et al. · 2026 · medRxiv preprint · AI summary available
    In short

    Standardized functional profiling of 303 French KCNH2 variants integrated with MeTAL modeling and calibrated ACMG evidence to reclassify 64 VUS.

  4. Related Broader context
    Phosphatidylserine receptors are critical for lethal infection by Crimean-Congo hemorrhagic fever virus
    J. Berrigan, S. R. Monticelli, M. D. Ramirez et al. · 2026 · bioRxiv preprint · AI summary available

    This study blocks phosphatidylserine receptors to protect mice from viral disease, unlike this paper’s AAV treatment for LRPPRC-deficient cardiomyopathy.

    In short

    AXL, TIM-1, and TIM-4 support CCHFV entry and disease; deleting two receptors protected mice in a lethal-challenge model.

  5. Related Broader context
    CSF PrP-amyloid seeding predicts clinical onset in inherited prion disease
    T. H. Mok, A. Nihat, S. M. Vallabh et al. · 2026 · medRxiv preprint · AI summary available

    This study tests whether CSF prion seeding predicts clinical onset in mutation carriers, while this paper evaluates gene replacement in a mouse model.

    In short

    In PRNP E200K carriers, CSF RT-QuIC positivity preceded clinical onset and marked substantially elevated near-term conversion risk.

  6. Related Broader context
    Stem Cell Therapy for Alzheimer's Disease
    Ankur Patel, Grishma joshi, Rupali Ugile · 2016 · Neurons and Cognition · preprint, not peer reviewed · cited 88 times · AI summary available

    This review discusses stem cell therapy for Alzheimer’s disease, rather than AAV-mediated LRPPRC replacement for mitochondrial cardiomyopathy.

    Abstract

    The loss of neuronal cells in the central nervous system may happen in numerous neurodegenerative illnesses. Alzheimer's Disease (AD) is an intricate, irreversible, dynamic neurodegenerative sickness. It is the main source of age-related dementia, influencing roughly 5.3 million individuals in the United States alone. Promotion is a typical feeble ailment in individuals more than 65 years, bringing on disability described by decrease in memory, failure to learn and do every day exercises, intellectual weakness and influences the personal satisfaction of patients. Pathologic qualities of AD are an irregular development of specific proteins called Beta-amyloid "plaques" and Tau "Tangles" in th…

  7. Related Broader context
    Genome analysis and pleiotropy assessment using causal networks with loss of function mutation and metabolomics
    Azam Yazdani, Akram Yazdani, Sarah H. Elsea et al. · 2019 · Genomics · cited 25 times · AI summary available

    This study links loss-of-function mutations to serum metabolites using causal networks, whereas this paper tests LRPPRC gene replacement in knockout mice.

    Abstract

    Background: Many genome-wide association studies have detected genomic regions associated with traits, yet understanding the functional causes of association often remains elusive. Utilizing systems approaches and focusing on intermediate molecular phenotypes might facilitate biologic understanding. Results: The availability of exome sequencing of two populations of African-Americans and European-Americans from the Atherosclerosis Risk in Communities study allowed us to investigate the effects of annotated loss-of-function (LoF) mutations on 122 serum metabolites. To assess the findings, we built metabolomic causal networks for each population separately and utilized structural equation mode…

  8. Related Broader context
    Robin: A multi-agent system for automating scientific discovery
    Ali Essam Ghareeb, Benjamin Chang, Ludovico Mitchener et al. · 2025 · Artificial Intelligence · preprint, not peer reviewed · cited 91 times · AI summary available

    Robin automates scientific discovery workflows, while this paper experimentally tests gene replacement in a mouse model of mitochondrial disease.

    Abstract

    Scientific discovery is driven by the iterative process of background research, hypothesis generation, experimentation, and data analysis. Despite recent advancements in applying artificial intelligence to scientific discovery, no system has yet automated all of these stages in a single workflow. Here, we introduce Robin, the first multi-agent system capable of fully automating the key intellectual steps of the scientific process. By integrating literature search agents with data analysis agents, Robin can generate hypotheses, propose experiments, interpret experimental results, and generate updated hypotheses, achieving a semi-autonomous approach to scientific discovery. By applying this sy…

How are these papers found?

We compare the title and abstract of this paper with those of every paper summarized on this site, and with the papers Semantic Scholar recommends, those it cites and those citing it (for a much-cited paper, its most recent citations and, from OpenAlex, the most cited ones). Among the prior work and the follow-ups, the papers that use each other in depth, a method it uses and the much-cited follow-ups come a little higher. The levels (very close, close, related) come from the similarity of the texts, not from a judgment of quality; * marks a paper without an abstract, compared by its title. The sentence under a paper is written by an AI from the two abstracts: check it in the papers. A paper marked not relevant by three readers leaves the list.

Updated on 16 November 2026.

The illustrated guide to the papers around a paper